Infoway Marketing: Investors ‘ interest холдингу in Si14 holding continues to grow

Infoway announced an increase in interest in the Pre-IPO of the Swiss holding Si14 AG after the presentation of the holding’s medical projects at the BRICS and BRICS+ International Summit in Dubai.

The holding is engaged in the implementation of colloidal technologies in the field of medicine in the BRICS countries. The drugs are based on nanoparticles of magnesium, zinc, copper and silver, which can effectively counteract infections.

Analysts and investors are showing increased interest in the Pre-IPO of the Swiss holding Si14 AG. The investment attractiveness of Si14 AG shares is growing after the holding introduced patented colloidal nanotechnologies in the pharmaceuticalindustry, according to Infoway Marketing, the official representative of Si14 AGInfoway Marketing.

The founder of the Swiss holding company Si14 AG is Viktor Kopylov. According to Viktor Kopylov, preparations based on colloidal technologies receive rave reviews. This applies not only to private users, but also to large partners at the state level.